Literature DB >> 22509760

IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis.

Ulrike Raap1, Sigo Weißmantel, Manuela Gehring, Anna M Eisenberg, Alexander Kapp, Regina Fölster-Holst.   

Abstract

Recently, we could show that IL-31 serum levels are significantly increased in adult patients with atopic dermatitis compared with skin healthy controls. However, the regulation of IL-31 in children with atopic dermatitis so far is not clear. Thus, we analyzed IL-31 serum levels together with IL-4, IL-13, ECP, and total IgE levels in 60 children with extrinsic, in five children with intrinsic atopic dermatitis, and 20 non-atopic healthy children. Further, we determined the SCORAD score, sleeplessness, and pruritus severity in all children with atopic dermatitis. IL-31 was significantly increased in children with the intrinsic and extrinsic type of atopic dermatitis compared with non-atopic healthy children (p < 0.05-0.001). Further, IL-31 serum levels significantly correlated with SCORAD score (p < 0.01), sleeplessness (p < 0.05), IL-4, and IL-13 levels (p < 0.01) in children with extrinsic atopic dermatitis. There was no correlation of IL-31 with pruritus, total IgE Ab, and ECP levels, whereas ECP levels significantly correlated with the SCORAD score in children with extrinsic atopic dermatitis. Together, IL-31 represents an interesting cytokine especially with regard to the severity of the inflammatory process indicated by the correlation of IL-31 with SCORAD score and Th2 cytokines including IL-4 and IL-13 in children with extrinsic atopic dermatitis.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22509760     DOI: 10.1111/j.1399-3038.2011.01241.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  39 in total

1.  IL-31 Induces Chemotaxis, Calcium Mobilization, Release of Reactive Oxygen Species, and CCL26 in Eosinophils, Which Are Capable to Release IL-31.

Authors:  Nikola Kunsleben; Urda Rüdrich; Manuela Gehring; Natalija Novak; Alexander Kapp; Ulrike Raap
Journal:  J Invest Dermatol       Date:  2015-03-19       Impact factor: 8.551

Review 2.  Molecular biology of atopic dermatitis.

Authors:  Zhanglei Mu; Yan Zhao; Xiaojing Liu; Christopher Chang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 3.  IL-31 Inhibition as a Therapeutic Approach for the Management of Chronic Pruritic Dermatoses.

Authors:  Youkyung S Roh; Justin Choi; Nishadh Sutaria; Micah Belzberg; Madan M Kwatra; Shawn G Kwatra
Journal:  Drugs       Date:  2021-04-21       Impact factor: 9.546

Review 4.  [Neurophysiology of atopic pruritus].

Authors:  N H Meyer; B Gibbs; M Schmelz; B Homey; U Raap
Journal:  Hautarzt       Date:  2018-03       Impact factor: 0.751

Review 5.  Itch mechanisms and circuits.

Authors:  Liang Han; Xinzhong Dong
Journal:  Annu Rev Biophys       Date:  2014       Impact factor: 12.981

6.  Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities.

Authors:  Filiberto Cedeno-Laurent; Elisha M Singer; Maria Wysocka; Bernice M Benoit; Carmela C Vittorio; Ellen J Kim; Gil Yosipovitch; Alain H Rook
Journal:  Clin Immunol       Date:  2015-03-08       Impact factor: 3.969

7.  Coriander alleviates 2,4-dinitrochlorobenzene-induced contact dermatitis-like skin lesions in mice.

Authors:  Gunhyuk Park; Hyo Geun Kim; Soonmin Lim; Wonil Lee; Yeomoon Sim; Myung Sook Oh
Journal:  J Med Food       Date:  2014-06-25       Impact factor: 2.786

8.  The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma.

Authors:  E Ferretti; C Tripodo; G Pagnan; C Guarnotta; D Marimpietri; M V Corrias; D Ribatti; S Zupo; G Fraternali-Orcioni; J L Ravetti; V Pistoia; A Corcione
Journal:  Leukemia       Date:  2014-10-06       Impact factor: 11.528

Review 9.  Physiology and Pathophysiology of Itch.

Authors:  Ferda Cevikbas; Ethan A Lerner
Journal:  Physiol Rev       Date:  2019-12-23       Impact factor: 37.312

Review 10.  New era of biologic therapeutics in atopic dermatitis.

Authors:  Emma Guttman-Yassky; Nikhil Dhingra; Donald Y M Leung
Journal:  Expert Opin Biol Ther       Date:  2013-01-16       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.